Sionna

Sionna Therapeutics is a life sciences company dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of the key protein CFTR, which is associated with CF disease progression. Founded in 2019, Sionna is advancing a series of small-molecule engineering efforts based on over a decade of extensive research into gene mutations related to CF.